Boron.

Boron influences how the body retains calcium, and early metabolic studies found it lowered the amount lost in urine, so more stays available for normal bone mineral metabolism. That shared role in bone is why the two minerals are so often paired in a formula.

Boron appears to reduce how much magnesium is lost in urine, and its effect on mineral balance grows more pronounced when magnesium intake is low, so the body tends to handle the two together. Magnesium supports the same bone and mineral processes boron influences.

Boron is reported to slow the hydroxylation and clearance steps that remove vitamin D metabolites, so circulating 25-hydroxyvitamin D tends to sit higher on the same intake. The pair is standard in bone formulas for that reason.

K2 carboxylates osteocalcin so mineral is directed into bone matrix, while boron acts on how much calcium and magnesium are retained rather than excreted. They work on separate halves of normal bone mineral turnover.

Silicon supports the collagen and glycosaminoglycan scaffold that mineral is laid down onto, and boron acts on the mineral side of that same scaffold.

Copper-dependent lysyl oxidase forms the cross-links that give bone collagen its tensile strength. Boron works on mineral retention in the same tissue, so the two cover matrix and mineral together.

Manganese is the metal cofactor for the glycosyltransferases that build cartilage and bone glycosaminoglycans, a step boron does not touch.

Zinc is the metal at the active site of bone alkaline phosphatase and supports normal steroid hormone production. Boron sits on the same axis by lowering sex hormone binding globulin, which raises the free hormone fraction.

Borate binds the cofactor site of S-adenosylhomocysteine hydrolase, which slows the step that clears the product of every SAM-e methyl transfer. That places boron on the methylation cycle SAM-e feeds.

Ascorbate has adjacent hydroxyls that borate can esterify reversibly, the same chemistry that lets borate bind sugars and nucleotides. In a dry blend nothing happens; in solution a fraction of both species exists as the complex. This is chemistry described in the solution phase and it has not been shown to change how much of either nutrient a person absorbs.

Inositol is a cyclitol with several cis-diol pairs, and borate binds polyols of that shape reversibly, which is why polyol-borate complexes are a standard part of borate solution chemistry. The practical relevance sits at the formulation level, in liquids and syrups where pH and water activity allow the complex to form. No human absorption consequence should be read into it.

Aminosugars carry the hydroxyl arrangement borate esterifies, so borate and glucosamine can associate in solution. Both are also used in products aimed at joint comfort and mobility, which is why the pair turns up together on labels. The overlap in use is a formulation fact; the chemistry is a solution interaction and neither one is evidence that the two act together in the body.

Boron influences how the kidney handles calcium and magnesium, and strontium is a divalent cation handled by the same bone mineral machinery that takes up calcium. Products built around supporting normal bone mineral density often carry both. The connection is a shared handling pathway inferred from mineral physiology rather than a tested combination, and strontium is measured by its incorporation into bone mineral, a marker rather than an outcome.

Bone mineral is a calcium phosphate lattice, and boron sits upstream of that lattice through its effect on calcium and magnesium retention and on the steroid and vitamin D metabolites that regulate them. Animal work on boron and bone measures mineral and enzyme endpoints alongside dietary phosphorus. Read this as two inputs to the same mineral pool, not as a demonstrated combined effect in people.

The ribose rings in NAD present cis-hydroxyls that borate binds, which is the classical explanation for borate inhibition of some dehydrogenases in vitro. That is enzyme chemistry measured in a tube at borate concentrations well above dietary intakes. It grounds a mechanism and says nothing about what happens at the microgram to low milligram boron intakes people actually take.

Borate crosslinks polysaccharide chains through hydroxyl esterification, the same chemistry that holds plant cell wall pectin together through rhamnogalacturonan II. Hyaluronan is a hydroxyl-rich polysaccharide, so the interaction is chemically plausible and shows up in gel and viscosity work. Nothing here bears on ingested hyaluronan or on joint tissue in a person.